Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

AntriaBio submits IND application for AB-101

June 6, 2017

Amgen submits applications in E.U. and U.S. for CV outcomes data for Repatha

June 6, 2017

Adocia begins two studies of BioChaperone products for diabetes

June 6, 2017

U.S. orphan designation given to recombinant fibroblast growth factor receptor 3 for achondroplasia

June 6, 2017

Etelcalcetide receives U.S. orphan designation for pediatric hyperparathyroidism

June 6, 2017

Biomarin Pharmaceutical wins E.U. approval of Brineura for CLN2

June 2, 2017

Alnylam's givosiran receives FDA breakthrough therapy designation

June 1, 2017

Nippon Boehringer Ingelheim and Kobe University enter diabetes agreement

May 31, 2017

Health Canada grants approval for Resverlogix's clinical trial of apabetalone in Fabry disease

May 30, 2017

Dasiglucagon receives positive opinion for designation as orphan medicinal product

May 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...